U2Bio's latest marketcap:
As of 07/21/2026, U2Bio's market capitalization has reached $50.83 M. According to our data, U2Bio is the 30580th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 50.83 M |
| Revenue (ttm) | 17.33 M |
| Net Income (ttm) | -1,111,897.33 |
| Shares Out | 16.32 M |
| EPS (ttm) | -0.1 |
| Forward PE | 0.00 |
| Ex-Dividend Date | 12/29/2025 |
| Earnings Date | n/a |
U2Bio's yearly market capitalization.
| Date | Market Cap(₩) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 07/21/2026 | ₩75.07 B | $50.83 M | 158.49% | 30580 |
| 12/30/2025 | ₩53.09 B | $36.08 M | 76.5% | 33244 |
| 12/30/2024 | ₩30.08 B | $20.15 M | -49.53% | 34115 |
| 12/28/2023 | ₩59.6 B | $45.89 M | 20.84% | 28356 |
| 12/29/2022 | ₩49.32 B | $38.96 M | -12.03% | 28584 |
| 12/30/2021 | ₩56.07 B | $47.09 M | 276.76% | 27921 |
| 12/30/2020 | ₩14.88 B | $0 | -39.54% | 31049 |
| 12/30/2019 | ₩24.61 B | $21.17 M | -15.36% | 26161 |
| 12/28/2018 | ₩29.08 B | $25.88 M | 35.4% | 24327 |
| 12/28/2017 | ₩21.48 B | $19.97 M | 25512 |
Company Profile
About U2Bio Co., Ltd.
U2Bio Co., Ltd. is a South Korean healthcare company specializing in innovative medical and biotechnology solutions. Established in 2009 and headquartered in Seoul, the company delivers a range of services aimed at improving patient care and health outcomes.
Core Services
- Clinical Laboratory Testing: Comprehensive diagnostic and testing services for accurate medical assessments.
- Digital Healthcare Solutions: Technology-driven services for health examinations and testing, enhancing accessibility and efficiency.
- Bio-Technology Platforms: Cutting-edge biotech tools and solutions to support research and healthcare advancements.
With a commitment to innovation, U2Bio Co., Ltd. continues to expand its contributions to the healthcare industry in South Korea and beyond.
Frequently Asked Questions
-
What is U2Bio's (KOSDAQ-221800) current market cap?As of 07/21/2026, U2Bio (including the parent company, if applicable) has an estimated market capitalization of $50.83 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does U2Bio (KOSDAQ-221800) rank globally by market cap?U2Bio global market capitalization ranking is approximately 30580 as of 07/21/2026. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.